Cohanim M, Yendt E R
Invest Urol. 1980 Sep;18(2):170-3.
We measured urinary oxalate by the method of Hallson and Rose before and during long-term thiazide therapy in 49 patients with recurrent urolithiasis. Urinary oxalate excretion in normal men and women on their usual diets was 38.8 +/- 10.3 mg per day (mean +/- SD) and in patients with calcific renal calculi was 45.9 +/- 14.3 mg per day. Hydrochlorothiazide produced a significant decrease in urinary oxalate excretion in patients treated for more than 12 months (33 +/- 10.6 mg per day). We believe that the thiazide-induced reduction of urinary oxalate excretion is related to reduced intestinal calcium absorption which has been shown during chronic thiazide therapy and may not be evident until 12 or more months of thiazide administration.
我们采用霍尔森和罗斯的方法,对49例复发性尿路结石患者在长期噻嗪类药物治疗前及治疗期间的尿草酸进行了测量。正常男女在日常饮食情况下尿草酸排泄量为每天38.8±10.3毫克(均值±标准差),患有钙化性肾结石的患者尿草酸排泄量为每天45.9±14.3毫克。接受超过12个月治疗的患者中,氢氯噻嗪使尿草酸排泄量显著降低(每天33±10.6毫克)。我们认为,噻嗪类药物引起的尿草酸排泄减少与肠道钙吸收减少有关,慢性噻嗪类药物治疗期间已证实存在这种情况,且可能在噻嗪类药物给药12个月或更长时间后才会显现。